Mead Johnson Nutrition (MJN)
Q2 2012 Earnings Call
July 26, 2012 9:30 am ET
Kathy Ann MacDonald - Vice President of Investor Relations and Acting Corporate Controller
Stephen W. Golsby - Chief Executive Officer, President and Director
Peter Kasper Jakobsen - Chief Operating Officer, Executive Vice President and Director
Peter G. Leemputte - Chief Financial Officer and Executive Vice President
Kenneth Goldman - JP Morgan Chase & Co, Research Division
Edward Aaron - RBC Capital Markets, LLC, Research Division
Matthew C. Grainger - Morgan Stanley, Research Division
Eric R. Katzman - Deutsche Bank AG, Research Division
Jason English - Goldman Sachs Group Inc., Research Division
David Driscoll - Citigroup Inc, Research Division
Bryan D. Spillane - BofA Merrill Lynch, Research Division
Good day, ladies and gentlemen, and welcome to the Mead Johnson Nutrition Second Quarter 2012 Earnings Conference Call. My name is Chanel, and I'll be your coordinator for today. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to Kathy MacDonald, Vice President, Investor Relations. Please proceed, Kathy.
Kathy Ann MacDonald
Thank you, and good morning. Welcome to Mead Johnson's second quarter conference call. Speaking today will be Steve Golsby, our Chief Financial Officer; Kasper Jakobsen, our Chief Operating Officer and CEO-elect; and Pete Leemputte, our Chief Financial Officer.
Before we get started, let me remind everyone that our comments will include forward-looking statements about our future results, including statements about our financial prospects and projections, new product launches and market conditions, that constitute forward-looking statements for purposes of the Safe Harbor Provision under the Private Securities Litigation Reform Act of 1995.